Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Holle

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Zeitschrift Fur Rheumatologie|December 19, 2012
[First genomewide association study of ANCA-associated vasculitis]J U Holle
Zeitschrift Fur Rheumatologie|June 8, 2013
[ANCA-associated vasculitis]J U Holle
Der Internist|December 16, 2014
[ANCA-associated vasculitis]J U Holle
Zeitschrift Fur Rheumatologie|May 14, 2020
[Treatment of giant cell arteritis: what is in the pipeline?]J U Holle, F Moosig
Zeitschrift Fur Rheumatologie|December 19, 2008
[ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations]J U Holle, P Lamprecht
Der Internist|November 13, 2013
[Genetic risk factors for vasculitis]J U Holle, W L Gross
Journal of Autoimmunity|April 7, 2009
ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapyJ U Holle, W L Gross
Zeitschrift Fur Rheumatologie|March 10, 2021
[Cortisone-free rheumatology-Distant vision or clinical routine soon?]J U Holle, C Fiehn, F Moosig
Clinical and Experimental Rheumatology|October 24, 2008
Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosisE Csernok, J U Holle, W L Gross
Der Internist|April 23, 2011
[Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)]J U Holle, F Moosig, W L Gross, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Zeitschrift Fur Rheumatologie|December 19, 2012
[First genomewide association study of ANCA-associated vasculitis]J U Holle
Zeitschrift Fur Rheumatologie|June 8, 2013
[ANCA-associated vasculitis]J U Holle
Der Internist|December 16, 2014
[ANCA-associated vasculitis]J U Holle
Zeitschrift Fur Rheumatologie|May 14, 2020
[Treatment of giant cell arteritis: what is in the pipeline?]J U Holle, F Moosig
Zeitschrift Fur Rheumatologie|December 19, 2008
[ANCA-associated vasculitides. Classifying the disease and its activity according to EULAR/EUVAS recommendations]J U Holle, P Lamprecht
Der Internist|November 13, 2013
[Genetic risk factors for vasculitis]J U Holle, W L Gross
Journal of Autoimmunity|April 7, 2009
ANCA-associated vasculitides: pathogenetic aspects and current evidence-based therapyJ U Holle, W L Gross
Zeitschrift Fur Rheumatologie|March 10, 2021
[Cortisone-free rheumatology-Distant vision or clinical routine soon?]J U Holle, C Fiehn, F Moosig
Clinical and Experimental Rheumatology|October 24, 2008
Proteinase 3, protease-activated receptor-2 and interleukin-32: linking innate and autoimmunity in Wegener's granulomatosisE Csernok, J U Holle, W L Gross
Der Internist|April 23, 2011
[Therapy of vasculitides: according to recommendations of the European League Against Rheumatism (EULAR) and European Vasculitis Study Group (EUVAS)]J U Holle, F Moosig, W L Gross, et al.
Pageof 4